Latest International Expansion News

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Vista Group has landed a significant contract to transition Cineplexx’s European cinema circuit to its cloud-based Operational Excellence platform, covering 59 sites and over 400 screens across 11 countries.

Cooks Coffee posted a 22.8% jump in UK and Ireland store sales for FY26, driving a 27% lift in normalised EBITDA. The company confirmed new store openings in Dubai and India, signalling a push into fast-growing international markets.

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

Tasmea Limited is set to acquire JPS Group for up to A$75 million, securing a foothold in Australia’s growing LNG and energy infrastructure sectors with a Tier-1 client base and a unique tech-enabled isolation technology.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

TALi Digital is transforming its established educational programs into an AI-driven platform, leveraging a validated cognitive technology and a national footprint in over 500 schools to tap a largely under-penetrated market.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Norwood Systems has landed a paid pilot trial with a major UK telecom to showcase its OpenSpan AI orchestration and CogVoice applications, marking a key step in its international expansion.